UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Smart Milli-capsules manipulated by nIR irradiation for controllable drug delivery in-vivo for renal cell carcinoma and neurodegenerative diseases

Jia, Rui; Li, Tian; Jiang, Weitao; Wang, Jing; Li, Xiao; Qu, Qiumin; Dang, Jingxia; (2022) Smart Milli-capsules manipulated by nIR irradiation for controllable drug delivery in-vivo for renal cell carcinoma and neurodegenerative diseases. Materials & Design , 224 , Article 111287. 10.1016/j.matdes.2022.111287. Green open access

[thumbnail of 2022-Smart Milli-capsules manipulated by nIR irradiation for controllable drug delivery in-vivo for renal cell carcinoma and neurodegenerative diseases.pdf]
Preview
Text
2022-Smart Milli-capsules manipulated by nIR irradiation for controllable drug delivery in-vivo for renal cell carcinoma and neurodegenerative diseases.pdf - Other

Download (3MB) | Preview

Abstract

Cancer and neurodegeneration which are responsible for million deaths worldwide, have urgent requests for drug administration with little to no side-effects. Current designs of drug-delivery, however, are constrained by either treatment effectiveness caused by imprecise control of drug-concentrations, or treatment-related toxicities caused by drugs-themselves or drug-carrier-systems, as well as the safety and feasibility. In this study, on account of the penetration ability through tissues of near-infrared (nIR) lights and the nIR-absorption ability of graphene oxide (GO), the GO-based milli-capsule is constructed, with controlled drug release ability by photomechanical deformation and wireless nIR manipulation. When radiation powers increasing from 0.1 to 0.5 W, drug dosages are in the range of 0 μg (0 drop) to 225 μg (five drops). The cytotoxicity of GO-based capsules in vitro is evaluated by embedded GO as drugs and released GO in clear cell renal cell carcinoma (ccRCC). When the capsules irradiated under 0.5 W and released different amounts of GO-drops in ccRCC, GO-concentrations increase from 0 to 80 μg∙mL−1 and the proportions of apoptotic cells increase 2.85 times, which proves milli-capsules inhibit ccRCC cells proliferation in a GO-concentration-dependent manner by accurate GO-dosing control. Other drugs such as siRNA furnishing an additional practicability-proof for neurodegeneration therapy.

Type: Article
Title: Smart Milli-capsules manipulated by nIR irradiation for controllable drug delivery in-vivo for renal cell carcinoma and neurodegenerative diseases
Open access status: An open access version is available from UCL Discovery
DOI: 10.1016/j.matdes.2022.111287
Publisher version: http://dx.doi.org/10.1016/j.matdes.2022.111287
Language: English
Additional information: © 2022 Xi'an Jiaotong University. Published by Elsevier Ltd. under a Creative Commons license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Keywords: Graphene oxide, Milli-capsule, Controlled release, nIR Irradiation, Cytotoxicity evaluation
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Department of Neuromuscular Diseases
URI: https://discovery.ucl.ac.uk/id/eprint/10193218
Downloads since deposit
3Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item